OverviewSuggest Edit

Recursion Pharmaceuticals combines innovative biological science with machine learning and deep learning to discover new therapeutic opportunities for rare genetic diseases - or any disease that they can model in cells. The Company uses high-throughput genetic manipulation to model many diseases in multiple human cell types quickly and efficiently. 
... Show more
TypePrivate
Founded2013
HQSalt Lake City, US
Websiterecursionpharma.com
Employee Ratings4.6

Latest Updates

Employees (est.) (Feb 2019)114(+3%)

Key People/Management at Recursion Pharmaceuticals

Chris Gibson

Chris Gibson

CEO

Recursion Pharmaceuticals Office Locations

Recursion Pharmaceuticals has an office in Salt Lake City
Salt Lake City, US (HQ)
300 630 Komas Dr
Show all (1)
Report incorrect company information

Recursion Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2013

Recursion Pharmaceuticals total Funding

$75.2 m

Recursion Pharmaceuticals latest funding size

$60 m

Time since last funding

a year ago

Recursion Pharmaceuticals investors

Recursion Pharmaceuticals's latest funding round in October 2017 was reported to be $60 m. In total, Recursion Pharmaceuticals has raised $75.2 m
View all funding rounds
Report incorrect company information

Recursion Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Recursion Pharmaceuticals News and Updates

Artificial Intelligence in Healthcare 2018 Global Market Key Players- Intel Corporation Nvidia Corporation Google IBM Corporation Microsoft Corporation General Vision Enlitic Next IT Welltok Icarbonx Recursion Pharmaceuticals Koninklijke Philips General

Wiseguyreports.Com Adds “Artificial Intelligence in Healthcare -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2023” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Biotech company Recursion Pharmaceuticals fetches $60 mln Series B

Salt Lake City-based Recursion Pharmaceuticals, a biotechnology company, has secured $60 million in Series B financing. Data Collective led the round.
Report incorrect company information

Recursion Pharmaceuticals Blogs

Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2

The post Artificial Intelligence Lights a Beacon to New Medicine for Neurofibromatosis Type 2 appeared first on Recursion Pharmaceuticals.

Recursion Pharmaceuticals Company Life and Culture

Report incorrect company information

Recursion Pharmaceuticals Frequently Asked Questions

  • When was Recursion Pharmaceuticals founded?

    Recursion Pharmaceuticals was founded in 2013.

  • Who are Recursion Pharmaceuticals key executives?

    Recursion Pharmaceuticals's key executives are Chris Gibson.

  • How many employees does Recursion Pharmaceuticals have?

    Recursion Pharmaceuticals has 114 employees.

  • Who are Recursion Pharmaceuticals competitors?

    Competitors of Recursion Pharmaceuticals include Biogen, MyoKardia and Athersys.

  • Where is Recursion Pharmaceuticals headquarters?

    Recursion Pharmaceuticals headquarters is located at 300 630 Komas Dr, Salt Lake City.

  • Where are Recursion Pharmaceuticals offices?

    Recursion Pharmaceuticals has an office in Salt Lake City.

  • How many offices does Recursion Pharmaceuticals have?

    Recursion Pharmaceuticals has 1 office.